Cosponsored by
BioE2E, QB3, UCSF Office of Technology Management,
and Wilson Sonsini Goodrich Rosati

In today's tough environment for VC funding, entrepreneurs need to access alternative funding sources – including government agencies and foundations.  US and state government agencies and philanthropic foundations provide funds and non-cash resources to small biotechnology companies with innovative technologies in the form of grants, contracts, screening services and other development assistance. Government grants and contracts can provide non-dilutive funding, validation from peers, feedback from experts and prestige, while services help you to advance programs while conserving cash.

Invited speakers and topics include:

• Defense Sciences Office, DARPA
• Michael Callahan MD, Program Manager
• The Joint Development Program (JTD) for Cancer Drug Development
• Joseph Tomaszewski, PhD, Deputy Director, Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (slides)
• Industry-University Collaborations
• Susanne Huttner, PhD, University of California Associate Vice Provost for Research (slides)
• Building your Company Without VC Money
• Dan Schwartz, MD, Founder, Calhoun Vision, Inc. and Associate Professor and Director of the Retina Division in the Department of Ophthalmology at UCSF (slides)
• Solicitations, Strategies and Discourse: Keys to Success for Funds
• Cori Gorman, PhD MBA, Principal, DNA Bridges (slides)
• The NIH SBIR/STTR Program, NIAID Programs, and Electronic Submission
• Gregory Milman, PhD, Director, Office for Innovation and Special Programs, Division of Extramural Activities, NIAID, NIH (slides)
• Stem Cell Funding in California - An Update from CIRM
• Gilberto Sambrano, PhD, Scientific Review Officer, California Institute for Regenerative medicine (CIRM) (slides)
• IP Issues for Grant Applications
• Laurence J Hyman, JD MSc, Townsend and Townsend and Crew (slides)
• Panel: Innovative Philanthropic Foundations Fund Emerging Biotech
• Panelists include Kate Carr, President & CEO Accelerate Brain Cancer Cure (ABC2), and Robert Pacifici and Tom Base of CHDI, Inc., the not-for-profit drug discovery-development arm of High Q Foundation
  • CHDI Slides
• Panel: Incubators and Accelerator

In addition to the speakers, representatives from the following organizations and resources will be available for consultation.

• SRI/ Pharmastart
  
• QB3 Garage
  
• San Jose Bioscience Center
  
• MMRI
  
• Wilson Sonsini Goodrich Rosati
  
• Grant Writing Services
  
• Angel Investor

  ---

Home

Upcoming Events

Steering Committee

Contact